目次

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Tinea Pedis (Athlete Foot) - Overview
Tinea Pedis (Athlete Foot) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Tinea Pedis (Athlete Foot) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Tinea Pedis (Athlete Foot) - Companies Involved in Therapeutics Development
Blueberry Therapeutics Ltd
DermBiont Inc
SaNOtize Research and Development Corp
Taro Pharmaceuticals USA Inc
Tinea Pedis (Athlete Foot) - Drug Profiles
DBI-001 - Drug Profile
Product Description
Mechanism Of Action
DBI-002 - Drug Profile
Product Description
Mechanism Of Action
NORS-6491 - Drug Profile
Product Description
Mechanism Of Action
TA-103 - Drug Profile
Product Description
Mechanism Of Action
terbinafine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
Tinea Pedis (Athlete Foot) - Dormant Projects
Tinea Pedis (Athlete Foot) - Product Development Milestones
Featured News & Press Releases
Oct 22, 2019: DermBiont announces positive data from phase 2a clinical trial and start of phase 2b clinical trial for Athlete’s Foot with a topical live biotherapeutic
Mar 13, 2019: DermBiont begins Phase 2 clinical trial for athlete's foot with a live bacterial topical probiotic
Nov 23, 2018: Blueberry reports positive results from Phase I/II BB2603 trial
Apr 26, 2017: Blueberry Therapeutics commence Phase I/II clinical trial of lead product BB2603
Apr 04, 2017: Mike Davies presents at the "Adaptive Designs in Clinical Trials" conference
Feb 28, 2017: Blueberry Therapeutics gains final approval for its first clinical trial
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Tinea Pedis (Athlete Foot), 2022
Number of Products under Development by Companies, 2022
Products under Development by Companies, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Tinea Pedis (Athlete Foot) - Pipeline by Blueberry Therapeutics Ltd, 2022
Tinea Pedis (Athlete Foot) - Pipeline by DermBiont Inc, 2022
Tinea Pedis (Athlete Foot) - Pipeline by SaNOtize Research and Development Corp, 2022
Tinea Pedis (Athlete Foot) - Pipeline by Taro Pharmaceuticals USA Inc, 2022
Tinea Pedis (Athlete Foot) - Dormant Projects, 2022
Tinea Pedis (Athlete Foot) - Dormant Projects, 2022 (Contd..1)

List of Figures
Number of Products under Development for Tinea Pedis (Athlete Foot), 2022
Number of Products under Development by Companies, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022